If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.



Manufacturers See Harm In Patent Bills

by Glenn Hess
January 26, 2009 | A version of this story appeared in Volume 87, Issue 4

Patent reform bills expected to be reintroduced in Congress this year would have several adverse effects on U.S. manufacturers, according to an industry group. A report issued by the Manufacturing Alliance on Patent Policy (MAPP), whose members include Dow Corning, DuPont, and Monsanto, concludes that provisions in the legislation designed to limit damage awards in patent infringement lawsuits would decrease the value of patented technologies by as much as $85 billion. The group further estimates that under the proposed changes R&D spending in the U.S. would decrease by up to $66 billion per year, and as many as 298,000 manufacturing jobs would be put at risk. Under the Patent Reform Act of 2007 (S. 1145, H.R. 1908), damage awards for infringement would be calculated according to the value of the component in question, rather than on the market value of the entire product. The congressional debate over patent reform has largely focused on the impact the legislation would have on the information-technology and biotech and pharma industries, but MAPP says it is "crucial for American policymakers to understand how the manufacturing sector will be affected by various proposals to change U.S. patent policy."


This article has been sent to the following recipient:

Chemistry matters. Join us to get the news you need.